UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gamma-delta (γδ) T cells: friend or foe in cancer development?

Journal of translational medicine, 2018-01, Vol.16 (1), p.3-13, Article 3

2018

Volltextzugriff (PDF)

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Biomarker research, 2020-08, Vol.8 (1), p.34-34, Article 34

2020

Volltextzugriff (PDF)

The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives

Frontiers in oncology, 2020-12, Vol.10, p.605154-605154

2020

Volltextzugriff (PDF)

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing

Frontiers in immunology, 2022-06, Vol.13, p.890166-890166

2022

Volltextzugriff (PDF)

Mechanisms of Cancer Resistance to Immunotherapy

Frontiers in oncology, 2020-08, Vol.10, p.1290-1290

2020

Volltextzugriff (PDF)

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1

Genome Biology, 2018-12, Vol.19 (1), p.218-218, Article 218

2018

Volltextzugriff (PDF)

Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy

Frontiers in immunology, 2022-05, Vol.13, p.886931-886931

2022

Volltextzugriff (PDF)

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy

Journal of experimental & clinical cancer research, 2019-09, Vol.38 (1), p.403-403, Article 403

2019

Volltextzugriff (PDF)

NK Cell Therapy: A Rising Star in Cancer Treatment

Cancers, 2021-08, Vol.13 (16), p.4129

2021

Volltextzugriff (PDF)

FLI-1-driven regulation of endothelial cells in human diseases

Journal of translational medicine, 2024-08, Vol.22 (1), p.740-14, Article 740

2024

Volltextzugriff (PDF)

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1501-1511

2021

Volltextzugriff (PDF)

Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies

Chinese medical journal, 2023-12, Vol.136 (23), p.2776-2786

2023

Volltextzugriff (PDF)

FLI1 Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer

Clinical cancer research, 2019-02, Vol.25 (4), p.1302-1317

2019

Volltextzugriff (PDF)

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

Chinese medical journal, 2024-01, Vol.137 (2), p.130-139

2024

Volltextzugriff (PDF)

Targeting the lactic acid metabolic pathway for antitumor therapy

Molecular therapy. Oncolytics, 2023-12, Vol.31, p.100740-100740, Article 100740

2023

Volltextzugriff (PDF)

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

Cancers, 2021-04, Vol.13 (8), p.1955

2021

Volltextzugriff (PDF)

Mechanism and clinical progression of solid tumors bone marrow metastasis

Frontiers in pharmacology, 2024-05, Vol.15, p.1390361-1390361

2024

Volltextzugriff (PDF)

Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation

Redox biology, 2018-04, Vol.14, p.609-617

2018

Volltextzugriff (PDF)

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

Journal of cancer research and clinical oncology, 2022, Vol.148 (1), p.163-176

2022

Volltextzugriff (PDF)

Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation

Oxidative medicine and cellular longevity, 2015-01, Vol.2015, p.407580-13

2015

Volltextzugriff (PDF)

Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1533-1546

2021

Volltextzugriff (PDF)

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients

Molecular and clinical oncology, 2017-09, Vol.7 (3), p.498-506

2017

Volltextzugriff (PDF)

Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer

Frontiers in oncology, 2020-10, Vol.10, p.575472-575472

2020

Volltextzugriff (PDF)

Hormetic Response to Low-Dose Radiation: Focus on the Immune System and Its Clinical Implications

International journal of molecular sciences, 2017-01, Vol.18 (2), p.280-280

2017

Volltextzugriff (PDF)

Anaplastic lymphoma kinase-special immunity and immunotherapy

Frontiers in immunology, 2022-07, Vol.13, p.908894

2022

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

Nur zeigenMit Volltextzugriff

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)

Publikationsform

Artikel
(280)
Tagungsberichte
(1)

Sprache

Englisch
(281)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Gamma-delta (γδ) T cells: friend or foe in cancer development?

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing

Mechanisms of Cancer Resistance to Immunotherapy

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1

Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy

NK Cell Therapy: A Rising Star in Cancer Treatment

FLI-1-driven regulation of endothelial cells in human diseases

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies

FLI1 Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

Targeting the lactic acid metabolic pathway for antitumor therapy

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

Mechanism and clinical progression of solid tumors bone marrow metastasis

Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation

Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients

Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer

Hormetic Response to Low-Dose Radiation: Focus on the Immune System and Its Clinical Implications

Anaplastic lymphoma kinase-special immunity and immunotherapy

Aktive Filter

Suchergebnisse filtern